We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Female Genital Mutilation (FGM) - February 2015, Experimental StatisticsOfficial statistics
- Publication Date:
- 27 Mar 2015
- Geographic Coverage:
- Geographical Granularity:
- Primary Care Organisations, Care Trusts, Regions, Country, Clinical Commissioning Groups, Local Authorities, Community health services, Hospital Trusts, NHS Trusts
- Date Range:
- 01 Feb 2015 to 28 Feb 2015
The Female Genital Mutilation Prevalence Dataset (ISB 1610) is a monthly return of data from acute hospital providers in England. It is an aggregated return of the incidence of FGM including women who have been previously identified and are currently being treated (for FGM related or non FGM related conditions as at the end of the month) and newly identified women within the reporting period. It has been a mandated collection from 1 September 2014.
For the month of February 2015:
- 129 of the 157 eligible acute trusts in England submitted signed off data.
- 2,477 active cases1 and 507 newly identified2 cases of FGM were reported nationally.
For the period of September 2014 to February 2015:
- 3,110 newly identified cases2 of FGM reported nationally.
- 46 newly identified2 cases of FGM reported nationally were under the age of 18. This is fewer than reported in the December 2014 publication for September to December 2014. This is due to revised data received from submitting hospital trusts.
- Patients identified as having a history of any FGM type prior to the reporting period and still being actively seen/treated for FGM-related conditions or any other non-related condition at the end of the month. Note: does not include those patients within NUMBER OF PATIENTS WITH FGM NEWLY IDENTIFIED IN REPORTING PERIOD (i.e. identified within this reporting period).
- Patients first identified during the reporting period as having undergone FGM. This will include those diagnosed/identified within the provider within the month.